Topics

Trump Administration Sues Gilead Over Truvada PReP for HIV Prevention

19:00 EST 6 Nov 2019 | BioSpace

HHS stated that Gilead had “willfully and deliberately induced infringement of the HHS patents.” As a result, “Gilead has profited from research funded by hundreds of millions of taxpayer dollars and reaped billions from PrEP,” through the sale of Truvada and Descovy.

Original Article: Trump Administration Sues Gilead Over Truvada PReP for HIV Prevention

NEXT ARTICLE

More From BioPortfolio on "Trump Administration Sues Gilead Over Truvada PReP for HIV Prevention"

Quick Search